S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
OTCMKTS:OTSKY

Otsuka Stock Forecast, Price & News

$17.97
+0.15 (+0.84%)
(As of 12/3/2021 03:59 PM ET)
Add
Compare
Today's Range
$17.82
$18.45
50-Day Range
$17.64
$21.92
52-Week Range
$17.18
$23.17
Volume
61,900 shs
Average Volume
44,812 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive OTSKY News and Ratings via Email

Sign-up to receive the latest news and ratings for Otsuka and its competitors with MarketBeat's FREE daily newsletter.


Otsuka logo

About Otsuka

Otsuka Holdings Co., Ltd. engages in the manufacture and sale of pharmaceuticals and nutritional supplements. It operates through the following business segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Others. The Pharmaceuticals segment manufactures therapeutic drugs and infusions focusing on the central nervous system, oncology, and infectious diseases. The Nutraceuticals segment develops and markets nutrition products such as nutritional food, quasi-drugs, health drinks, and dietary supplements for homes, medical facilities, and nursing care units. The Consumer Products segment sells mineral water, food, and beverages. Its products include Bon Curry, Mannan Hikari, and ReSOLA. The Others segment distributes functional and fine chemicals, optical inspection devices, and clinical diagnosis equipment. The company was founded in1950 and is headquartered in Tokyo, Japan.

Headlines

Otsuka (OTCMKTS:OTSKY) Updates FY 2021 Earnings Guidance
December 3, 2021 |  americanbankingnews.com
Otsuka (OTCMKTS:OTSKY) Releases FY 2021 Earnings Guidance
November 26, 2021 |  americanbankingnews.com
Otsuka (OTCMKTS:OTSKY) Issues FY 2021 Earnings Guidance
November 12, 2021 |  americanbankingnews.com
Avanir Pharmaceuticals Named One of Orange County's Best Places to Work
November 1, 2020 |  markets.businessinsider.com
Otsuka Holdings Co. Ltd. ADR
July 23, 2020 |  www.wsj.com
See More Headlines

Industry, Sector and Symbol

Industry
Drug Manufacturers - Major
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:OTSKY
Fax
N/A
Employees
33,151
Year Founded
N/A

Sales & Book Value

Annual Sales
N/A

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Optionable
Not Optionable

MarketRank

Overall MarketRank

0.96 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -












Otsuka (OTCMKTS:OTSKY) Frequently Asked Questions

Is Otsuka a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Otsuka in the last year. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Otsuka stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OTSKY, but not buy additional shares or sell existing shares.
View analyst ratings for Otsuka
or view top-rated stocks.

How has Otsuka's stock been impacted by COVID-19 (Coronavirus)?

Otsuka's stock was trading at $17.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, OTSKY shares have increased by 1.2% and is now trading at $17.97.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Otsuka?

Otsuka saw a decrease in short interest in November. As of November 15th, there was short interest totaling 1,900 shares, a decrease of 84.4% from the October 31st total of 12,200 shares. Based on an average trading volume of 122,600 shares, the days-to-cover ratio is presently 0.0 days.
View Otsuka's Short Interest
.

What guidance has Otsuka issued on next quarter's earnings?

Otsuka issued an update on its FY 2021 earnings guidance on Friday, December, 3rd. The company provided EPS guidance of $2.720-$2.720 for the period. The company issued revenue guidance of $13.58 billion-$13.58 billion.

Who are Otsuka's key executives?

Otsuka's management team includes the following people:
  • Tatsuo Higuchi, President, CEO & Representative Director
  • Yuko Makino, Chief Financial Officer & Director
  • Frank Czerwiec, Vice President-Global Clinical Development
  • Yasuhisa Kurogi, Head-Business Development
  • Shuichi Takagi, Director & Head-Business Portfolio Management

What is Otsuka's stock symbol?

Otsuka trades on the OTCMKTS under the ticker symbol "OTSKY."

How do I buy shares of Otsuka?

Shares of OTSKY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Otsuka's stock price today?

One share of OTSKY stock can currently be purchased for approximately $17.97.

How many employees does Otsuka have?

Otsuka employs 33,151 workers across the globe.

What is Otsuka's official website?

The official website for Otsuka is www.otsuka.com.

How can I contact Otsuka?

The company can be reached via phone at (136) 717-1410.


This page was last updated on 12/6/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.